Published Papers
Robinson RL, Shahida
S, Madan N, Rao S, Khardori N. Transient parkinsonism in West Nile
virus encephalitis. Am J Med. 2003 Aug 15;115(3):252-3.
Barenfanger J, Arakere
P, Cruz RD, Imran A, Drake C, Lawhorn J, Verhulst SJ, Khardori N.
Improved outcomes associated with limiting identification of Candida
spp. in respiratory secretions. J Clin Microbiol. 2003 Dec;41(12):5645-9.
Jain S, Koirala J, Castro-Pavia
F. Isolated gastrointestinal histoplasmosis: case report and review
of the literature. South Med J. 2004 Feb;97(2):172-4.
Kanchanapoom T, Koirala
J, Goodrich J, Agamah E, Khardori N. Treatment of central nervous
system infection by vancomycin-resistant enterococcus faecium.
Diagn Microbiol Infect Dis. 2003 Mar;45(3):213-5.
Temesgen Z, Cainelli F,
Warnke D, Koirala J. Initial antiretroviral therapy in chronically-infected
HIV-positive adults. Expert Opin Pharmacother. 2004 Mar;5(3):595-612.
El-Azizi MA, Starks SE,
Khardori N. Interactions of Candida albicans with other Candida spp.
and bacteria in the biofilms. J Appl Microbiol. 2004;96(5):1067-73.
Koirala J. Trimethoprim-sulfamethoxazole--induced
methemoglobinemia in an HIV-infected patient.Mayo Clin Proc. 2004
Jun;79(6):829-30.
Koirala J, Basnet S. Botulism,
Botulinum Toxin, and Bioterrorism: Review and Update. Infect Med
2004 Jun; 21:284-290.
Nancy Khardori and Sail
Gulati. Management of infections in patients with moderate to severe
burns. Infection Control Resource. 2004; 3: 1-7.
El-Azizi M, Rao S, Kanchanapoom
T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin,
and linezolid against intact and disrupted biofilms of staphylococci.
Ann Clin Microbiol Antimicrob. 2005 Jan 7;4(1):2
El-Azizi M, and N. Khardori.
2004. Non-antibacterial antibiotic effects: Staphylococcus epidermidis
biofilms and quinolones. Antibiotics for Clinicians 8: 285-286.
Nancy Khardori. Overview
of biological terrorism: Potential agents and preparedness. Clinical
Microbiology Newsletter. 2005; 27: 1-8.
Nancy Khardori. Preparedness
for bioterrorism. Molecular Cell Biology and Molecular Medicine. 2005;
10: 507-528.
El-Azizi M, A. Mushtaq,
C. Drake, J. Lawhorn, J. Barenfanger, S. Verhulst, and N. Khardori
(2005). Evaluating antibiograms to monitor drug resistance. Emerging
Infectious Diseases 11 (8) 1302-3
Darouiche RO, Berger DH,
Khardori N, Robertson CS, Wall MJ Jr, Metzler MH, Shah S, Mansouri
MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II.Comparison
of antimicrobial impregnation with tunneling of long-term central
venous catheters: a randomized controlled trial. Ann Surg. 2005 242(2):193-200.
Nancy Khardori. (2006).
Potential agents of bioterrorism: Historical perspective and an overview.
In: Nancy Khardori, editors. Bioterrorism preparedness. WILEY-VCH
VERLAG Gmbh & CO. Germany; p. 1-31.
Nancy Khardori. (2006).
Bioterrorism prepardness: Historical perspective and an overview.
In: Nancy Khardori, editors. Bioterrorism preparedness. WILEY-VCH
VERLAG Gmbh & CO. Germany; p. 33-59.
Nancy Khardori. (2006).
Anthrax-Clinical presentation, and management. In: Nancy Khardori,
editors. Bioterrorism preparedness. WILEY-VCH VERLAG Gmbh & CO.
Germany; p. 123-145.
Koirala J. (2006). Plague:
Endemic, Epidemic and Bioterrorism. In: Nancy Khardori, editors. Bioterrorism
preparedness. WILEY-VCH VERLAG Gmbh & CO. Germany; p. 147-162.
Koirala J. (2006). Botulism:
Toxicology, Clinical Presentations and Management. In: Nancy Khardori,
editors. Bioterrorism preparedness. WILEY-VCH VERLAG Gmbh & CO.
Germany; p. 163-180.
Koirala J. (2006). Tularemia:
Natural Disease versus Act of Terrorism. In: Nancy Khardori, editors.
Bioterrorism preparedness. WILEY-VCH VERLAG Gmbh & CO. Germany;
p. 181-194.
Subbash Chaudhry. (2006).
Care of children in the event of bioterrorism. In: Nancy Khardori,
editors. Bioterrorism preparedness. WILEY-VCH VERLAG Gmbh & CO.
Germany; p. 73-92.
James Goodrich. (2006).
Small Pox, clinical presentation and prevention. In: Nancy Khardori,
editors. Bioterrorism preparedness. WILEY-VCH VERLAG Gmbh & CO.
Germany; p. 93-121.
James Goodrich. (2006).
Viral hemorrhagic fever: Differentiation of natural diseases from
act of bioterrorism. . In: Nancy Khardori, editors. Bioterrorism
preparedness. WILEY-VCH VERLAG Gmbh & CO. Germany; p. 195-224.
Khardori N. Editor. Bioterrorism.
Infectious Disease Clinics of North America. Elsevier Publishers,
June 2006.
Khardori, N. Bioterrorism
and Bioterrorism Preparedness: A Historical perspective and overview.
In Bioterrorism – Infectious Disease Clinics of North America,
June 2006.
Kyriacou, D.N., Adamski,
A. and Khardori, N. Anthrax – From antiquity and obscurity
to a front runner in bioterrorism.
In Bioterrorism – Infectious Disease Clinics of North America,
June 2006.
Mushtaq, A., El-Azizi,
M. and Khardori, N. Category C potential bioterrorism agents and
emerging pathogens.
In Bioterrorism – Infectious Disease Clinics of North America,
June 2006.
Khardori, N. Antibiotics:
Past, present and future. In Medical Clinics of North America, June
2006.
Mushtaq, A., El-Azizi,
M. and Khardori, N. Effects of mucin on biofilm formation of methicillin
resistant Staphylococcus aureus (MRSA) on endotracheal tube –
A major determinant in ventilator associated pneumonia (VAP). 46th
Annual ICAAC, San Francisco, CA, September, 2006.
Mushtaq, A., El-Azizi,
M. and Khardori, N. Role of albumin on colonization of methicillin
resistant Staphylococcus aureus (MRSA) on endotracheal tube in vitro
- A major determinant in ventilator associated pneumonia (VAP).44th
Annual IDSA, Toronto, Ontario, Canada, October, 2006.
Abstracts:
Madan, N., Rao, S. Robert,
R. Shahida S. and Khardori, N. Transient Parkinsonism: An unusual
manifestation of West Nile virus encephalitis. American College
of Physicians. American Society of Internal Medicine. San Diego,
California, April, 2003.
Koirala, J., Powless,
C., Louis-Jacques, P., Ryan, B. and Khardori, N. Self-treatment
of diarrhea in International Travelers. International Society of
Travel Medicine, New York, New York, May, 2003.
Spiker, C., Arakere, P. Mushtaq, A. and Khardori, N. In vitro antimicrobial
susceptibility of linezolid against gram positive cocci in suspension,
biofilms and resuspended biofilms. European Congress of Clinical
Microbiology and Infectious Diseases, Glasgow, United Kingdom, May,
2003.
Havener, G. Roth, M. Arakere, P. Mottar, T, Barenfanger, J. Milner
S. and Khardori, N. Effective investigation and Control of an aspergillosis
outbreak in a Regional Burn Unit. Association of Practitioners in
Infection Control, National Meeting, San Antonio, Texas, June, 2003.
El-Azizi, M. S. Starks
and N. Khardori. 2003. effects of combination of Amphotericin with
Azithromycin, Clarithromycin, Erythromycin, Gentamycin and Rifampin
against clinical isolates of Candida species and filamentous fungi.43rd
Interscience Conference of Antimicrobial Agent and Chemotherapy
(ICAAC), Chicago, USA.
El-Azizi, M. and N. Khardori.
2003. Effects of Amphotericin B on mature biofilms of Candida albicans
in an in vitro pharmacokinetic model. American Society for Microbiology,
Biofilms 2003, Victoria, British Coloumbia, Canada.
Koirala, L. Koch. Interferon-Gamma
and Interferon-Gamma R1 in HIV Infection. Abstracts of 11th International
Congress on Infectious Diseases. Int J Infect Dis, 2004 Mar; 8:S32.
El-Azizi, M. and N. Khardori.
2004. In vitro synergism between linezolid and UV radiation against
biofilms of Staphylococcus aureus. 14th European Congress of Clinical
Microbiology and Infectious Diseases. Czech Republic, Prague..
N. Khardori, M. El-Azizi,
A. Mushtaq, C. Ball, C. Drake, J. Lawhorn. 2004. Region specificity,
frequency of occurrence and pattern of antimicrobial susceptibility
of common bacterial infections in Central Illinois. 14th European
Congress of Clinical Microbiology and Infectious Diseases. Czech
Republic, Prague.
El-Azizi, M. Suma Rao
and Nancy Khardori. 2004. In vitro activity of Synercid, Vancomycin
and linezolid against clinical isolates of MRSA, MSSA and S. epidermidis
in suspensions, biofilms and dispersed biofilms. 104th general meeting
of American Society for Microbiology, New orleans, LA, USA.
Suma Rao, M. El-Azizi,
and Nancy Khardori. 2004. Effect of Vancomycin, Quinupristin/dalfopristin
and linezolid on the production of extracellular polymeric materials
produced by S. epidermidis. 44th Interscience Conference of Antimicrobial
Agent and Chemotherapy (ICAAC), Washington, DC, USA.
Roth, M., Cooley, N.
Havener, G. and Khardori, N. Cost effective way for handling Crueztfeld
Jacob Disease (JD) contaminated surgical instruments. Association
for Practitioners in Infection Control, National Meeting, June,
2004.
Barenfanger, J., Daly,
J.A., Hall, G.. Korgenski, E.K., Ramsey, D., Sreedhar, R., Agha,
A., Gandotra, S., Mushtaq, A. and Khardori, N. 2005. Comprehension
of microbiology reports by health care workers. 105th General Meeting
of ASM, Atlanta, Georgia, USA.
S. Rao, D. Blessman,
J. Koirala, J. Goodrich, and N. Khardori. 2005. Biological response
modifier as adjunct treatment for refractory localized MAC infection.
CR 2005. Washington, D.C., USA.
B. Henkle, M. El-Azizi,
A. Entabi, F. Malal, N. Khardori. 2005. Double and triple combinations
of ciprofloxacin with other antipseudomonal drugs against multidrug
resistant isolates of Pseudomonas aeruginosa in vitro. The15th European
Congress of Clinical Microbiology and Infectious Diseases. Copenhagen,
Denmark.
M. El Azizi, S. D. Gandotra,
P. Likibi, N. Khardori. 2005. A Comparison of the Bactericidal Activity
of Three New Percarboxylic Acids Disinfectants ( 1-2K, 1-2KM, 3-3K)
to that of Peracetic Acid, Glutaraldehyde, Hydrogen Peroxide and
Sodium Hypochlorite Against Multidrug Resistant Bacteria. 105th
General Meeting of ASM, Atlanta, Georgia, USA.
S. D. Gandotra, M. El-Azizi,
P. Likibi, N. Khardori. 2005. Factors Affecting the Killing Efficacy
of New Percarboxylic Acid Disinfectant (1-2K) Against Multidrug
Resistant Bacteria. The105th General Meeting of ASM, Atlanta, Georgia,
USA.
S. Klotz, N. Gaur, M.
El-Azizi, N. Khardori, Sheppard, and P. Lipke. 2005. Candida albicans
Als Proteins Mediate Polymicrobial Aggregation. 105th General Meeting
of ASM, Atlanta, Georgia, USA.
Janak Koirala, Alys Adamski,
Lori Koch, Mohammed El-Azizi, Nancy Khardori. Expression of Interferon-Gamma
Receptors Increases with Progression of HIV-1 Infection. 43rd Annual
Meeting of the Infectious Diseases Society of America (IDSA), San
Francisco, October 6-9, 2005 (Abstract no. 167).
Janak Koirala, Susheer
D. Gandotra, Suma Rao, Donna Blessman, Mary Spain, Nancy Khardori.
Appropriate Dosing of G-CSF in Pegylated Interferon-alpha Induced
Neutropenia. 43rd Annual Meeting of the Infectious Diseases Society
of America (IDSA), San Francisco, October 6-9, 2005 (Abstract no.
957)
M. El-Azizi, S. Bhat,
P. Savage, S. Milner, and N. Khardori. Topical Applications of Cationic
Steroid Antimicrobial (CSA-13) in Treatment of Burn Wound Colonization
by Pseudomonas aeruginosa in Burned Mice. 45th ICAAC, 2005. Washington
DC, USA.
S.Gandotra, M. El-Azizi,
and N. Khardori. In vitro activity of eight antimicrobial agents against
clinical isolates of Stenotrophomonas maltophilia. 45th ICAAC, 2005.
Washington DC, USA.
S. Gandotra, M. El-Azizi,
and N. Khardori. 2006. In vitro combination of rifampin with other
antimicrobial agents against clinical isolates of Stenotrophomonas
maltophilia. The 16th European Congress of Clinical Microbiology and
Infectious Diseases. Nice, France.
M. El-Azizi, A. Mushtaq,
and Nancy Khardori.2006. Activity of Peracetic Acid, Glutaraldehyde,
Hydrogen Peroxide and Sodium Hypochlorite Against the biofilms of
Multidrug Resistant Bacteria.106th General Meeting of ASM, Orlando,
Florida, USA.
Top